Market Place
Sourcing Support
All News #Library
Janssen`s Biologic Talvey (talquetamab) Receives Approval in the U.S.
09 Aug 2023 //
FDA
Janssen`s Rekambys (Rilpivirine) Receives Approval in Europe
08 Jun 2023 //
EMA
Janssen`s Biologic Stelara (Ustekinumab) Receives Approval in the U.S.
06 Mar 2023 //
FDA
Janssen`s Biologic Rybrevant (Amivantamab) Receives Approval in the U.S.
04 Nov 2022 //
FDA
Janssen`s Tecvayli (Teclistamab) Receives Approval in Europe
13 Oct 2022 //
EMA
Janssen BioTech Stelara (ustekinumab) Receives BLA Approval Approval in U.S.
30 Jul 2022 //
FDA
Janssen`s Chemical Spravato (Esketamine HCl) Receives Approval in the U.S.
03 Jan 2022 //
FDA
Janssen`s Biologic Darzalex Faspro gets Approval in the U.S.
30 Nov 2021 //
FDA
Janssen`s Ponesimod Receives Approval In US
19 Mar 2021 //
FDA
Janssen Biotech`s Biological Golimumab Receives Approval In US
29 Sep 2020 //
FDA
Janssen Biotech`s Darzalex (Dartumumab) Receives Supplemental Approval in US
21 Aug 2020 //
FDA
Janssen Biotech`s Tremfya (Guselkumab ) Receives Supplemental Approval in US
16 Jul 2020 //
FDA
Janssen-Cilag Generic Paliperidone palmitate Receives Approval in Europe
07 Jul 2020 //
EMA
Janssen Biotech`s Tremfya (Guselkumab ) Receives Supplemental Approval in US
03 Jun 2020 //
FDA
Janssen Biotech`s TREMFYA (Guselkumab) Receives Supplemental Approval in US
23 Nov 2019 //
FDA
Janssen Biotech`s Generic Ustekinuma Receives Approval in US
09 Nov 2019 //
FDA
Janssen Biotech Darzalex (Daratumumab) Receives Supplemental Approval in US
26 Sep 2019 //
FDA
Janssen-Cilag NV`s Erleada (Apalutamide) Receives Approval in Europe
22 Mar 2019 //
EMA
Janssen`s Darzalex (Daratumumab) Receives Supplemental Approval in US
08 Feb 2019 //
FDA
Janssen`s Tremfya (Guselkumab) Receives Supplemental Approval in US
29 Jan 2019 //
FDA
Janssen`s Trevicta Receives Approval in Europe
20 Oct 2018 //
EMA
Janssen`s Stelara (Ustekinumab) Receives Approval in EU
11 Oct 2018 //
EMA
Janssen`s Invokana (canagliflozin) Receives Approval in Europe
04 Oct 2018 //
EMA
Actelion`s Opsumit (macitentan) Receives Marketing Approval in EU
04 Oct 2018 //
EMA
Janssen-Cilag`s Invokana (canagliflozin) Receives Approval in Europe
04 Oct 2018 //
EMA
Janssen-Cilag Internatl`s Darzalex (daratumumab) Receives Approval in Europe
29 Sep 2018 //
EMA
Janssen Biotech Daratumumab Receives Supplemental Approval In US
08 May 2018 //
FDA
Janssen-Cilag International Generic Symtuza Receives Approval In Europe
27 Sep 2017 //
EMA
Janssen’s Tremfya Guselkumab Receives Approval Supplemental In US
12 Jul 2017 //
FDA
Janssen`s Supplement Simponi Aria (Golimumab) Receives Approval In US
30 Jan 2017 //
FDA
Janssen`s Supplement Daratumumab Receives Approval In US
21 Nov 2016 //
FDA
Janssen`s Supplementary Daratumumab (Darzalex) Receives Approval In US
18 Nov 2016 //
FDA
Janssen`s Vermox (Mebendazole) Approved In US
19 Oct 2016 //
FDA
Janssen Pharms Canagliflozin;Metformin Hydrochloride Approved In US
20 Sep 2016 //
FDA
Actelion`s Uptravi (Selexipag) approved in US for Hypertension
22 Dec 2015 //
FDA
Janssen`s Duragesic (Fentanyl) Approved in US For Anesthesia
30 Jun 2015 //
FDA
Johnson & Johnson’s Rezolsta Approved in the EU for HIV-1
12 Dec 2014 //
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.